ZIKA Vaccine in Naive Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 14, 2016

Primary Completion Date

December 5, 2018

Study Completion Date

December 5, 2018

Conditions

Zika Virus Infection

Interventions

DRUG

Saline

Sodium chloride solution.

BIOLOGICAL

Zika Virus Purified Inactivated Vaccine (ZPIV)

Zika Virus Purified Inactivated Vaccine with aluminum hydroxide adjuvant.

Trial Locations (1)

Saint Louis University Center for Vaccine Development, St Louis

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02952833 - ZIKA Vaccine in Naive Subjects | Biotech Hunter | Biotech Hunter